Condition: Monoclonal Gammopathy of Undetermined Significance (MGUS) · Smoldering Multiple Myeloma (SMM) · Sponsor: Regeneron Pharmaceuticals
This study is researching an investigational drug called linvoseltamab ("study drug") in participants at moderate risk of developing multiple myeloma (about 3 to 10% average annual risk), a group that consists of patients with precancerous conditions called High-Risk Monoclonal Gammopathy of Undetermined Significance (HR-MGUS) and Non-High-Risk Smoldering Multiple Myeloma (NHR-SMM). The primary purpose of the study is to understand how well the study drug can eliminate abnormal plasma cells and laboratory signs of HR-MGUS and NHR-SMM. The study is looking at several other research questions, including: * How many participants treated with linvoseltamab have improvement of their HR-MGUS or NHR-SMM? * What side effects may happen from taking the study drug? * How much study drug is in the blood at different times? * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects).
This description comes directly from the study's public registry record.
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Always discuss trial participation with your own doctor first.
| Johns Hopkins Hospital | Baltimore, Maryland, United States | Recruiting |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| University of Michigan Health | Ann Arbor, Michigan, United States | Recruiting |
| NYU Langone Health Perlmutter Cancer Center | New York, New York, United States | Recruiting |
| Stony Brook University Hospital | Stony Brook, New York, United States | Recruiting |
| Thomas Jefferson University Hospital | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Washington | Seattle, Washington, United States | Recruiting |
| Algemeen Ziekenhuis (AZ) Klina | Brasschaat, Antwerpen, Belgium | Recruiting |
| AZ St.-Elisabeth Herentals vzw | Herentals, Antwerp, Belgium | Recruiting |
| AZ Sint Maarten Algemeen Ziekenhuis Emmaus | Mechelen, Flanders, Belgium | Recruiting |
| Algemeen Ziekenhuis St Jan Brugge Oostende Av | Bruges, West-Vlaanderen, Belgium | Recruiting |
| Algemeen Ziekenhuis AZ Delta | Roeselare, West-Vlaanderen, Belgium | Recruiting |
+ 27 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06140524